Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

fludarabine 3Cyclophosphamide 3Busulfan 2venetoclax 1trametinib 1luspatercept 1gilteritinib 1dabrafenib 1Whole-Body Irradiation 1Vancomycin 1Thiotepa 1Teicoplanin 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Radiosurgery 1Ofloxacin 1NF protocol 1Mycophenolic Acid 1Metronidazole 1Meropenem 1Kidney Transplantation 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Cytarabine 1Complementary Therapies 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hematologic Neoplasms × Basiliximab × Clear all
NCT06480630 2024-06-28

Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

Anhui Provincial Hospital

Phase 2 Not yet recruiting
39 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡